A detailed history of California Public Employees Retirement System transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 6,089,766 shares of GILD stock, worth $569 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
6,089,766
Previous 6,373,763 4.46%
Holding current value
$569 Million
Previous $437 Million 16.73%
% of portfolio
0.36%
Previous 0.32%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$66.59 - $83.99 $18.9 Million - $23.9 Million
-283,997 Reduced 4.46%
6,089,766 $510 Million
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $74.9 Million - $86.4 Million
-1,185,503 Reduced 15.68%
6,373,763 $437 Million
Q1 2024

Apr 30, 2024

SELL
$71.58 - $87.29 $20.4 Million - $24.9 Million
-285,068 Reduced 3.63%
7,559,266 $554 Million
Q4 2023

Feb 01, 2024

SELL
$73.27 - $83.09 $8.07 Million - $9.15 Million
-110,126 Reduced 1.38%
7,844,334 $635 Million
Q3 2023

Nov 02, 2023

BUY
$73.94 - $80.67 $583,904 - $637,050
7,897 Added 0.1%
7,954,460 $596 Million
Q2 2023

Aug 09, 2023

SELL
$76.01 - $86.7 $18 Million - $20.5 Million
-236,709 Reduced 2.89%
7,946,563 $612 Million
Q1 2023

May 12, 2023

SELL
$77.31 - $88.08 $34.5 Million - $39.3 Million
-446,729 Reduced 5.18%
8,183,272 $679 Million
Q4 2022

Feb 08, 2023

SELL
$62.32 - $89.47 $21.5 Million - $30.8 Million
-344,541 Reduced 3.84%
8,630,001 $741 Million
Q3 2022

Nov 09, 2022

SELL
$59.54 - $68.01 $13.7 Million - $15.6 Million
-229,411 Reduced 2.49%
8,974,542 $554 Million
Q2 2022

Aug 10, 2022

SELL
$57.72 - $65.01 $13 Million - $14.6 Million
-224,950 Reduced 2.39%
9,203,953 $569 Million
Q1 2022

May 04, 2022

SELL
$57.92 - $72.58 $7.25 Million - $9.08 Million
-125,099 Reduced 1.31%
9,428,903 $561 Million
Q4 2021

Feb 10, 2022

SELL
$64.88 - $73.64 $17.3 Million - $19.6 Million
-265,891 Reduced 2.71%
9,554,002 $694 Million
Q3 2021

Nov 10, 2021

BUY
$67.69 - $73.03 $2.33 Million - $2.51 Million
34,383 Added 0.35%
9,819,893 $686 Million
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $3.25 Million - $3.56 Million
-51,284 Reduced 0.52%
9,785,510 $674 Million
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $20.1 Million - $22.9 Million
-334,971 Reduced 3.29%
9,836,794 $636 Million
Q4 2020

Feb 02, 2021

SELL
$56.65 - $64.55 $17.6 Million - $20 Million
-309,862 Reduced 2.96%
10,171,765 $593 Million
Q3 2020

Nov 05, 2020

SELL
$62.1 - $78.08 $2.89 Million - $3.63 Million
-46,530 Reduced 0.44%
10,481,627 $662 Million
Q2 2020

Aug 12, 2020

BUY
$72.34 - $84.0 $447 Million - $519 Million
6,175,064 Added 141.85%
10,528,157 $810 Million
Q1 2020

May 12, 2020

BUY
$62.63 - $80.22 $79.5 Million - $102 Million
1,268,791 Added 41.14%
4,353,093 $325 Million
Q4 2019

Jan 27, 2020

SELL
$61.62 - $67.78 $18 Million - $19.8 Million
-292,222 Reduced 8.65%
3,084,302 $200 Million
Q3 2019

Oct 31, 2019

BUY
$62.51 - $69.0 $35.1 Million - $38.7 Million
561,195 Added 19.93%
3,376,524 $214 Million
Q2 2019

Aug 15, 2019

SELL
$61.87 - $69.38 $18.5 Million - $20.8 Million
-299,703 Reduced 9.62%
2,815,329 $190 Million
Q1 2019

May 03, 2019

SELL
$62.53 - $70.05 $7.83 Million - $8.77 Million
-125,241 Reduced 3.87%
3,115,032 $203 Million
Q4 2018

Feb 08, 2019

SELL
$60.54 - $79.0 $5.95 Million - $7.76 Million
-98,253 Reduced 2.94%
3,240,273 $203 Million
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $12.5 Million - $13.8 Million
-174,685 Reduced 4.97%
3,338,526 $258 Million
Q2 2018

Aug 15, 2018

BUY
$64.88 - $75.68 $2.34 Million - $2.73 Million
36,098 Added 1.04%
3,513,211 $249 Million
Q1 2018

May 11, 2018

BUY
$72.84 - $88.8 $439,516 - $535,819
6,034 Added 0.17%
3,477,113 $262 Million
Q4 2017

Feb 06, 2018

BUY
$71.15 - $83.52 $14 Million - $16.5 Million
197,317 Added 6.03%
3,471,079 $249 Million
Q3 2017

Nov 15, 2017

BUY
$72.11 - $85.47 $236 Million - $280 Million
3,273,762
3,273,762 $265 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.